Literature DB >> 34511864

Pharmacotherapeutic options for weight regain after bariatric surgery.

Chika Vera Anekwe1,2, Michael G Knight3, Sujatha Seetharaman1, Wesley P Dutton1, Shradha M Chhabria4, Fatima Cody Stanford2,5.   

Abstract

PURPOSE OF REVIEW: We sought to critically evaluate the recent literature published over the past 3 years on the topic of weight regain after bariatric surgery in children, adolescents, and adults, with an emphasis on clinically- relevant information for pharmacologic treatment of weight regain after metabolic and bariatric surgery.
FINDINGS: There are multiple pharmacotherapeutic agents available to treat obesity in children, adolescents, and adults; these agents have varying efficacy and indications for use and have been studied in a variety of clinical and research scenarios. We present an overview of these findings.
SUMMARY: This review represents a comprehensive compilation of the recently published data on efficacy of anti-obesity pharmacotherapy in the treatment of weight regain after bariatric surgery for children, adolescents, and adults.

Entities:  

Keywords:  adolescence; anti-obesity pharmacotherapy; bariatric surgery; obesity; pediatric; weight regain

Year:  2021        PMID: 34511864      PMCID: PMC8425280          DOI: 10.1007/s11938-021-00358-7

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  74 in total

1.  Efficacy of High-Dose Liraglutide as an Adjunct for Weight Loss in Patients with Prior Bariatric Surgery.

Authors:  Peter Rye; Renuca Modi; Sarah Cawsey; Arya M Sharma
Journal:  Obes Surg       Date:  2018-11       Impact factor: 4.129

2.  Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials.

Authors:  Karine Clément; Erica van den Akker; Jesús Argente; Allison Bahm; Wendy K Chung; Hillori Connors; Kathleen De Waele; I Sadaf Farooqi; Julie Gonneau-Lejeune; Gregory Gordon; Katja Kohlsdorf; Christine Poitou; Lia Puder; James Swain; Murray Stewart; Guojun Yuan; Martin Wabitsch; Peter Kühnen
Journal:  Lancet Diabetes Endocrinol       Date:  2020-10-30       Impact factor: 32.069

3.  Metformin for Treatment of Overweight Induced by Atypical Antipsychotic Medication in Young People With Autism Spectrum Disorder: A Randomized Clinical Trial.

Authors:  Evdokia Anagnostou; Michael G Aman; Benjamin L Handen; Kevin B Sanders; Amy Shui; Jill A Hollway; Jessica Brian; L Eugene Arnold; Lucia Capano; Jessica A Hellings; Eric Butter; Deepali Mankad; Rameshwari Tumuluru; Jessica Kettel; Cassandra R Newsom; Stasia Hadjiyannakis; Naomi Peleg; Dina Odrobina; Sarah McAuliffe-Bellin; Pearl Zakroysky; Sarah Marler; Alexis Wagner; Taylor Wong; Eric A Macklin; Jeremy Veenstra-VanderWeele
Journal:  JAMA Psychiatry       Date:  2016-09-01       Impact factor: 21.596

4.  Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial.

Authors:  Thomas A Wadden; John P Foreyt; Gary D Foster; James O Hill; Samuel Klein; Patrick M O'Neil; Michael G Perri; F Xavier Pi-Sunyer; Cheryl L Rock; Janelle S Erickson; Holly N Maier; Dennis D Kim; Eduardo Dunayevich
Journal:  Obesity (Silver Spring)       Date:  2010-06-17       Impact factor: 5.002

5.  Meal replacements followed by topiramate for the treatment of adolescent severe obesity: A pilot randomized controlled trial.

Authors:  Claudia K Fox; Alexander M Kaizer; Kyle D Rudser; Brandon M Nathan; Amy C Gross; Muna Sunni; M Jennifer Abuzzahab; Betsy L Schwartz; Seema Kumar; Anna Petryk; Charles J Billington; Justin R Ryder; Aaron S Kelly
Journal:  Obesity (Silver Spring)       Date:  2016-11-03       Impact factor: 5.002

Review 6.  Efficacy and safety of topiramate on weight loss: a meta-analysis of randomized controlled trials.

Authors:  C K Kramer; C B Leitão; L C Pinto; L H Canani; M J Azevedo; J L Gross
Journal:  Obes Rev       Date:  2011-03-28       Impact factor: 9.213

Review 7.  Weight Regain After Bariatric Surgery: Prevalence, Etiology, and Treatment.

Authors:  Saketh R Velapati; Meera Shah; Aravind R Kuchkuntla; Barham Abu-Dayyeh; Karen Grothe; Ryan T Hurt; Manpreet S Mundi
Journal:  Curr Nutr Rep       Date:  2018-12

8.  Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency.

Authors:  Tinh-Hai Collet; Béatrice Dubern; Jacek Mokrosinski; Hillori Connors; Julia M Keogh; Edson Mendes de Oliveira; Elana Henning; Christine Poitou-Bernert; Jean-Michel Oppert; Patrick Tounian; Florence Marchelli; Rohia Alili; Johanne Le Beyec; Dominique Pépin; Jean-Marc Lacorte; Andrew Gottesdiener; Rebecca Bounds; Shubh Sharma; Cathy Folster; Bart Henderson; Stephen O'Rahilly; Elizabeth Stoner; Keith Gottesdiener; Brandon L Panaro; Roger D Cone; Karine Clément; I Sadaf Farooqi; Lex H T Van der Ploeg
Journal:  Mol Metab       Date:  2017-07-08       Impact factor: 7.422

Review 9.  Clinical Considerations Regarding the Use of Obesity Pharmacotherapy in Adolescents with Obesity.

Authors:  Gitanjali Srivastava; Claudia K Fox; Aaron S Kelly; Ania M Jastreboff; Allen F Browne; Nancy T Browne; Janey S A Pratt; Christopher Bolling; Marc P Michalsky; Stephen Cook; Carine M Lenders; Caroline M Apovian
Journal:  Obesity (Silver Spring)       Date:  2019-02       Impact factor: 5.002

Review 10.  Screening for Obesity and Intervention for Weight Management in Children and Adolescents: Evidence Report and Systematic Review for the US Preventive Services Task Force.

Authors:  Elizabeth A O'Connor; Corinne V Evans; Brittany U Burda; Emily S Walsh; Michelle Eder; Paula Lozano
Journal:  JAMA       Date:  2017-06-20       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.